The Impact of Excise Tax Structures for Retail Marijuana on Marijuana Consumption

May 7, 2026 updated by: Ce Shang, Ohio State University

The investigators will follow probability-based cohorts of adult non-medical marijuana users (N=1,500; ages 21+) and susceptible adolescents and young adults (AYA) users (N=1,000; ages 15-20) over four years. The investigators will use a prospective survey to collect marijuana use information and will conduct volumetric choice experiments (VCEs) where participants choose quantities to purchase among three legal product prototypes: flower, edible, and concentrate; and one illegal flower product, under simulated retail marijuana tax structures. The presentation of edibles and concentrates will change over time to capture the range of product varieties in the market and to accommodate new products and characteristics as they evolve. Choice experiments including VCEs use a series of manipulations as a measurement device to elicit preferences for products and consumption. Therefore, the experimental design is within-subjects with repeated measures, which allow for causal identifications of the impact of design attributes (e.g., tax bases and rates) on preference and consumption outcomes. The attributes and levels are selected to reflect THC levels in the market, existing (weight, price, tiered price by forms) and novel (potency) tax bases, existing (10%-40% of retail price or equivalent in other bases) and potential (high 60% and 80% of retail prices or equivalent) tax rates, and price distribution for each product. Price distribution levels (5 to 95 percentiles) will come from our price data collection and will be updated over time and vary by participants' state and locality of residence.

Before the experiment, study personnel will instruct participants 1) how to answer the choice experiment question, including considering their weekly expenditures when answering VCE questions; 2) that there is no access to other products, no stockpiling, no selling or giving away products to others, etc., to ensure that participants choose products that reflect their usual purchase patterns for self-use; 3) that there are no right or wrong responses. Study personnel will instruct participants to answer all questions honestly, thoughtfully, and to the best of their understanding as if they were actually in this situation, to reduce hypothetical bias; 4) that there may be potential costs or issues associated with purchasing illegal products, including risks of penalties, undefined potency, possible contamination, and inconsistent product quality; and 5) that participants should keep their weekly budget in mind when making purchase choices of the products. In VCEs, the investigators will manipulate THC levels, tax rates and bases, and price levels. Participants will be asked to answer the following: "Imagine these are the marijuana products that you (participants) can purchase for non-medical use, how many of each product would you (participants) most likely buy next time?" Participants can choose more than one product, and as they choose quantities, the total balance will be displayed. To make the tasks easier, study personnel will 1) set a warning to inform participants if their reported budget exceeds their weekly budget for spending; 2) provide a dropdown list for quantities or, if they would like more units than the listed, they can fill in a number; and 3) all products are described as high-quality to allow for a comparison of prices. Half of the participants will be randomized to see itemized pre-tax tag price, excise taxes, and sales taxes, as requested in some states (e.g., Illinois); the other half will be randomized to see only prices that are inclusive of excise taxes. This will allow us to whether excise taxes are more effective when applied at checkout compared to hidden in the tag prices.

Study Overview

Study Type

Interventional

Enrollment (Actual)

4696

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Columbus, Ohio, United States, 43214
        • Center for Tobacco Research OSU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion:

Adults:

  • aged 21 years and older
  • must be past-30-day dual users of recreational marijuana Adolescents and young adults
  • ages 15-20
  • susceptible to marijuana use

Exclusion:

  • adults older than 21 years who are not using marijuana for recreational purposes
  • youth under age 15
  • teens and young adults who are not susceptible to marijuana use

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Tax structure arm 1
Participants are randomized into seeing WEIGHT based taxes for recreational cannabis, then they make hypothetical purchases in responses to products with different THC levels, prices, and taxes.
Arm 1 intervention is weight based taxes on cannabis, where participants make hypothetical purchases under weight based taxes.
Other: Tax structure arm 2
Participants are randomized into seeing PRICE based taxes for recreational cannabis, then they make hypothetical purchases in responses to products with different THC levels, prices, and taxes.
Arm 2 intervention is price based taxes on cannabis, where participants make hypothetical purchases under price based taxes.
Other: Tax structure arm 3
Participants are randomized into seeing potency based taxes for recreational cannabis, then they make hypothetical purchases in responses to products with different THC levels, prices, and taxes.
Arm 3 intervention is potency based taxes on cannabis, where participants make hypothetical purchases under potency based taxes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hypothetical purchase decisions (Unit purchased)
Time Frame: Measures will be collected at baseline, 6 month follow up, 12 month follow up, and the 18 month follow up.
Number of units that participants intend to purchase, if taxes and prices are set at a certain level.
Measures will be collected at baseline, 6 month follow up, 12 month follow up, and the 18 month follow up.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Whether to make a hypothetical purchase
Time Frame: Measures will be collected at baseline, 6 month follow up, 12 month follow up, and the 18 month follow up.
Dichotomous variable: 0= not purchasing; and 1= purchasing
Measures will be collected at baseline, 6 month follow up, 12 month follow up, and the 18 month follow up.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 17, 2024

Primary Completion (Actual)

April 10, 2026

Study Completion (Actual)

April 10, 2026

Study Registration Dates

First Submitted

February 14, 2025

First Submitted That Met QC Criteria

February 21, 2025

First Posted (Actual)

February 27, 2025

Study Record Updates

Last Update Posted (Actual)

May 11, 2026

Last Update Submitted That Met QC Criteria

May 7, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • osu-2022B0032
  • R01DA053294 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypothetical Cannabis Purchase

Clinical Trials on Arm 1 Intervention

Subscribe